SEC Filings | Allogene Therapeutics

Filing date	Description	Form	View
Nov 05, 2019	S-3ASR	S-3ASR	0001737287-19-000022.pdf 0001737287-19-000022.rtf 0001737287-19-000022.xls View HTML
Nov 05, 2019	Report of unscheduled material events or corporate event	8-K	0001737287-19-000023.pdf 0001737287-19-000023.rtf 0001737287-19-000023.xls View HTML
Oct 29, 2019	Statement of changes in beneficial ownership of securities	4	0001214659-19-006702.pdf 0001214659-19-006702.rtf View HTML
Oct 29, 2019	Statement of changes in beneficial ownership of securities	4	0001214659-19-006703.pdf 0001214659-19-006703.rtf View HTML
Sep 25, 2019	Statement of changes in beneficial ownership of securities	4	0001214659-19-006019.pdf 0001214659-19-006019.rtf View HTML
Sep 25, 2019	Statement of changes in beneficial ownership of securities	4	0001214659-19-006021.pdf 0001214659-19-006021.rtf View HTML
Sep 18, 2019	Statement of changes in beneficial ownership of securities	4	0001214659-19-005941.pdf 0001214659-19-005941.rtf View HTML
Sep 09, 2019	Statement of changes in beneficial ownership of securities	4	0001214659-19-005741.pdf 0001214659-19-005741.rtf View HTML
Sep 09, 2019	Statement of changes in beneficial ownership of securities	4	0001214659-19-005740.pdf 0001214659-19-005740.rtf View HTML
Sep 05, 2019	Statement of changes in beneficial ownership of securities	4	0001214659-19-005669.pdf 0001214659-19-005669.rtf View HTML

Data provided by Kaleidoscope.